Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00456586
Status:
COMPLETED
Last Update Posted:
2024-04-25
First Post:
2007-04-03
Brief Title:
12-Week Double-Blind Placebo-Controlled Randomized Study of the Efficacy of 40 mgDay KW-6002 in Parkinsons Disease Patients on LevodopaCarbidopa
Sponsor:
Organization:
Kyowa Kirin Co Ltd
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
180
Enrollment Type:
None
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: